Literature DB >> 1789519

Chemoprophylactic effects of milbemycin oxime against larvae of Dirofilaria immitis during prepatent development.

R B Grieve1, G R Frank, V A Stewart, J C Parsons, D L Belasco, D I Hepler.   

Abstract

Three studies were conducted to determine the efficacy of milbemycin oxime in the prevention of Dirofilaria immitis infection in dogs. Dogs were given single or multiple experimental inoculations with infective third-stage D immitis larvae and were treated with milbemycin oxime at a target dosage of 0.5 mg/kg of body weight either once or at monthly intervals at various times after inoculation. The compound was effective in preventing infection when 1 dose was administered 30 or 45 days after inoculation. Significant, but incomplete, protection was achieved when single treatments were administered 60 or 90 days after inoculation. Multiple monthly treatments beginning 60 days after inoculation appeared to provide additive effects that resulted in restoration of complete efficacy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1789519

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  9 in total

1.  A serological survey of Dirofilaria immitis infection in pet dogs of Busan, Korea, and effects of chemoprophylaxis.

Authors:  Kang Hyun Byeon; Bong Jin Kim; Sun-Mi Kim; Hak Sun Yu; Hae Jin Jeong; Mee-Sun Ock
Journal:  Korean J Parasitol       Date:  2007-03       Impact factor: 1.341

2.  Canine heartworm testing in Canada: are we being effective?

Authors:  K C Klotins; S W Martin; B N Bonnett; A S Peregrine
Journal:  Can Vet J       Date:  2000-12       Impact factor: 1.008

3.  Percutaneous heartworm removal from dogs with severe heart worm (Dirofilaria immitis) infestation.

Authors:  Seung-Gon Lee; Hyeong-Sun Moon; Changbaig Hyun
Journal:  J Vet Sci       Date:  2008-06       Impact factor: 1.672

4.  Comparative palatability of two veterinary dewormers (Milpro(®) and Milbemax(®)): a blinded randomised crossover cat study.

Authors:  N Bernachon; D McGahie; D Corvaisier; E Benizeau; N Crastes; G Chaix
Journal:  Vet Rec Open       Date:  2014-12-30

5.  Mosquito-borne heartworm Dirofilaria immitis in dogs from Australia.

Authors:  Chloe Nguyen; Wei Ling Koh; Andrea Casteriano; Niek Beijerink; Christopher Godfrey; Graeme Brown; David Emery; Jan Šlapeta
Journal:  Parasit Vectors       Date:  2016-10-07       Impact factor: 3.876

6.  A statistical approach for evaluating the effectiveness of heartworm preventive drugs: what does 100% efficacy really mean?

Authors:  Anand N Vidyashankar; Pablo D Jimenez Castro; Ray M Kaplan
Journal:  Parasit Vectors       Date:  2017-11-09       Impact factor: 3.876

Review 7.  Examination of the "susceptibility gap" in the treatment of canine heartworm infection.

Authors:  Dwight D Bowman; Jason Drake
Journal:  Parasit Vectors       Date:  2017-11-09       Impact factor: 3.876

8.  Efficacy of four commercially available heartworm preventive products against the JYD-34 laboratory strain of Dirofilaria immitis.

Authors:  Byron L Blagburn; Robert G Arther; Allen R Dillon; Jamie M Butler; Joy V Bowles; Cristiano von Simson; Robert Zolynas
Journal:  Parasit Vectors       Date:  2016-04-05       Impact factor: 3.876

9.  Laboratory and field studies to investigate the efficacy of a novel, orally administered combination product containing moxidectin, sarolaner and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs.

Authors:  Kristina Kryda; Robert H Six; Kelly F Walsh; Susan J Holzmer; Sara Chapin; Sean P Mahabir; Melanie Myers; Tammy Inskeep; Jady Rugg; Blair Cundiff; Aleah Pullins; Michael Ulrich; John W McCall; Tom L McTier; Steven J Maeder
Journal:  Parasit Vectors       Date:  2019-09-11       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.